Pharmacopées, ouvrages relatifs à la pharmacie et aux médicaments

<p>POTASSIUM CLAVULANATE - REFERENCE SPECTRUM</p>

<p>POLYSORBATE 60 - REFERENCE SPECTRUM</p>

<p>ETHANOL 96% - REFERENCE SPECTRUM</p>

<p>PHENYLMERCURIC ACETATE - REFERENCE SPECTRUM</p>

<p>MALIC ACID - REFERENCE SPECTRUM</p>

<p>LEUPRORELIN - REFERENCE SPECTRUM</p>

<p>MUPIROCIN CALCIUM - REFERENCE SPECTRUM</p>

<p>SODIUM PROPIONATE - REFERENCE SPECTRUM</p>

<p>FLUORESCEINE SODIUM - REFERENCE SPECTRUM</p>

<p>TRIMETAZIDINE DIHYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>ETHYL ACETATE - REFERENCE SPECTRUM</p>

<p>NITRIC OXIDE - REFERENCE SPECTRUM</p>

<p>NICOTINE - REFERENCE SPECTRUM</p>

<p>ISOFLURANE - REFERENCE SPECTRUM</p>

<p>CARBON DIOXIDE - REFERENCE SPECTRUM</p>

<p>CLONAZEPAM - REFERENCE SPECTRUM</p>

<p>TRIACETIN - REFERENCE SPECTRUM</p>

<p>ALMAGATE - REFERENCE SPECTRUM</p>

<p>VINBLASTINE SULFATE - REFERENCE SPECTRUM</p>

<p>CARBON MONOXIDE - REFERENCE SPECTRUM</p>

<p>N-METHYLPYRROLIDONE - REFERENCE SPECTRUM</p>

<p>FOSFOMYCIN SODIUM - REFERENCE SPECTRUM</p>

<p>CLOBAZAM - REFERENCE SPECTRUM</p>

<p>ACECLOFENAC - REFERENCE SPECTRUM</p>

<p>POLYSORBATE 20 - REFERENCE SPECTRUM</p>

<p>TILIDINE HYDROCHLORIDE HEMIHYDRATE - REFERENCE SPECTRUM</p>

<p>PARAFFIN (LIQUID) - REFERENCE SPECTRUM</p>

<p>PENTAZOCINE HYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>TIANEPTINE SODIUM - REFERENCE SPECTRUM</p>

<p>TACALCITOL MONOHYDRATE - REFERENCE SPECTRUM</p>

<p>LEVAMISOLE - REFERENCE SPECTRUM</p>

<p>CARBOPLATIN - REFERENCE SPECTRUM</p>

<p>HYDROUS BENZOYL PEROXIDE - REFERENCE SPECTRUM</p>

<p>FLUNITRAZEPAM - REFERENCE SPECTRUM</p>

<p>FLURAZEPAM MONOHYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>DIHYDRALAZINE SULFATE (HYDRATED) - REFERENCE SPECTRUM</p>

<p>Available to order from July 2022 / Effective from 1 January 2023<br><br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 11th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 11.0 published in July 2022,<br>Supplement 11.1 published in October 2022,<br>Supplement 11.2 published in January 2023.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.</p>

<p>La Pharmacopée Européenne (Ph. Eur.) est un ouvrage de référence unique en matière de contrôle qualité des médicaments. Les normes officielles qui y sont publiées fournissent une base scientifique au contrôle qualité durant toute la vie des médicaments.<br><br>Ces normes sont juridiquement contraignantes — ce qui est expressément stipulé dans la Convention relative à l’élaboration d’une Pharmacopée européenne et dans les législations pharmaceutiques nationales et de l’UE. Les normes qualité de la Ph. Eur. deviennent d’application obligatoire à la même date dans tous les États Parties à la convention.<br><br><br>La 10e Édition en bref<br><br> • Juridiquement contraignante dans 39 pays d’Europe et appliquée dans plus de 120 pays du monde entier<br> • Contient des nouveaux textes et des textes révisés<br> • Divulgue des informations essentielles pour les marchés européens avant toutes les autres pharmacopées<br> • La 10e Edition (Supplément 10.5 inclus) comprend 2447 monographies (y compris les formes pharmaceutiques), 378 textes généraux (y compris les monographies générales et méthodes d’analyse) et environ 2800 descriptions de réactifs.<br><br><br>Calendrier de parution<br><br>La 10e Édition de la Ph. Eur. a été publiée en juillet 2019 et sera complétée par huit suppléments périodiques (10.1 à 10.8) au cours des trois années suivantes. <br><br>Volume 10.0 publiée en juillet 2019,<br>Supplément 10.1 publiée en octobre 2019,<br>Supplément 10.2 publiée en janvier 2020.<br><br><br>Version papier<br><br>La 10e Édition est composée de trois volumes initiaux (10.0), complétés par huit suppléments non cumulatifs (10.1 à 10.8). Par souci de commodité des utilisateurs, un accès direct aux informations complémentaires (base de données Knowledge) est inclus pour chaque monographie et chaque chapitre général (code Datamatrix). Disponible en français ou en anglais, la version papier contient une clé d’activation (code EPID) qui donne accès aux archives en ligne.</p>

<p>MELPHALAN - REFERENCE SPECTRUM</p>

<p>METRONIDAZOLE BENZOATE - REFERENCE SPECTRUM</p>

<p>METHANOL - REFERENCE SPECTRUM</p>

<p>TRIETHYL CITRATE - REFERENCE SPECTRUM</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 11th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 11th Edition of the Ph. Eur. was released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8). <br><br>Supplement 11.0 published in July 2022,<br>Supplement 11.1 published in October 2022 and<br>Supplement 11.2 published in January 2023.<br><br><br>Print version<br><br>The 11th Edition consists of three initial volumes (11.0) complemented by eight non-cumulative supplements (11.1 to 11.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.<br></p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>TThe 2023 subscriptions to the European Pharmacopoeia (Ph. Eur.), including the initial release (11.0) and the first two supplements (11.1-11.2), are now available for sale in the WebStore of the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM).<br><br>The 11th Edition key facts and figures<br>New edition, legally binding in 39 European countries as of 1 January 2023 and applied in more than 130 countries worldwide.<br>Continuously updated and modernised to meet users' needs. <br>The 11th Edition of the Ph. Eur. contains:<br>2 469 monographs (including dosage forms);<br>386 general texts (including general monographs and methods of analysis);<br>and more than 2 800 descriptions of reagents.<br>Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).<br><br>Subscribers may choose either of the two formats proposed:<br><br>Online version<br>access, in English and French, until 31 December 2023 to the content of the initial release (11.0) and two cumulative updates (11.1 and 11.2)<br>tablet and smartphone friendly: access via all recent common operating systems (Windows, Linux and Mac compatible)<br><br>Print<br>available in English or French<br>includes the first three volumes (11.0) and two non-cumulative updates (11.1 and 11.2)<br>Other highlights:<br><br>Access to the Ph. Eur. online archives is included in all our subscriptions.<br>Special prices for multiple and unlimited licences are available for the online version.<br>A package including both formats is available at a special price.<br></p>

<p>CARTEOLOL HYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Supplement 10.3 published in July 2020,<br>Supplement 10.4 published in October 2020 and<br>Supplement 10.5 published in January 2021.<br><br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>METHADONE HYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>CALCIPOTRIOL (ANHYDROUS) - REFERENCE SPECTRUM</p>

<p>(Available in 2022)<br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br><br>The subscription contains 3 issues in English:<br><br>Supplement 10.6 published in July 2021,<br>Supplement 10.7 published in October 2021 and<br>Supplement 10.8 published in January 2022.<br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>CALCITRIOL - REFERENCE SPECTRUM</p>

<p>CEFOPERAZONE SODIUM - REFERENCE SPECTRUM</p>

<p>CARBOPROST TROMETAMOL - REFERENCE SPECTRUM</p>

<p>METHYLENE CHLORIDE - REFERENCE SPECTRUM</p>

<p>La Pharmacopée Européenne (Ph. Eur.) est un ouvrage de référence unique en matière de contrôle qualité des médicaments. Les normes officielles qui y sont publiées fournissent une base scientifique au contrôle qualité durant toute la vie des médicaments.<br><br>Ces normes sont juridiquement contraignantes — ce qui est expressément stipulé dans la Convention relative à l’élaboration d’une Pharmacopée européenne et dans les législations pharmaceutiques nationales et de l’UE. Les normes qualité de la Ph. Eur. deviennent d’application obligatoire à la même date dans tous les États Parties à la convention.<br><br><br>La 10e Édition en bref<br><br> • Juridiquement contraignante dans 39 pays d’Europe et appliquée dans plus de 120 pays du monde entier<br> • Contient des nouveaux textes et des textes révisés<br> • Divulgue des informations essentielles pour les marchés européens avant toutes les autres pharmacopées<br> • La 10e Edition (Supplément 10.5 inclus) comprend 2447 monographies (y compris les formes pharmaceutiques), 378 textes généraux (y compris les monographies générales et méthodes d’analyse) et environ 2800 descriptions de réactifs.<br><br><br>Calendrier de parution<br><br>La 10e Édition de la Ph. Eur. a été publiée en juillet 2019 et sera complétée par huit suppléments périodiques (10.1 à 10.8) au cours des trois années suivantes. <br><br>Supplément 10.3 publiée en juillet 2020,<br>Supplément 10.4 publiée en octobre 2020,<br>Supplément 10.5 publiée en janvier 2021.<br><br><br>Version papier<br><br>La 10e Édition est composée de trois volumes initiaux (10.0), complétés par huit suppléments non cumulatifs (10.1 à 10.8). Par souci de commodité des utilisateurs, un accès direct aux informations complémentaires (base de données Knowledge) est inclus pour chaque monographie et chaque chapitre général (code Datamatrix). Disponible en français ou en anglais, la version papier contient une clé d’activation (code EPID) qui donne accès aux archives en ligne.</p>

<p>PENTAZOCINE - REFERENCE SPECTRUM</p>

<p>ZUCLOPENTHIXOL DECANOATE - REFERENCE SPECTRUM</p>

<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 10.0 published in July 2019,<br>Supplement 10.1 published in October 2019,<br>Supplement 10.2 published in January 2020.<br><br><br>Print version<br><br>The 10th Edition consists of three initial volumes (10.0) complemented by eight non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.</p>

<p>CARBASALATE CALCIUM - REFERENCE SPECTRUM</p>

<p>PROPANOL - REFERENCE SPECTRUM</p>

<p>N,N-DIMETHYLACETAMIDE - REFERENCE SPECTRUM</p>

<p>CALCIFEDIOL - REFERENCE SPECTRUM</p>

<p>ALFACALCIDOL - REFERENCE SPECTRUM</p>

<p>SODIUM POLYSTYRENE SULFONATE - REFERENCE SPECTRUM</p>

<p>TIAMULIN - REFERENCE SPECTRUM</p>

<p>SODIUM HYALURONATE - REFERENCE SPECTRUM</p>

<p>THEOPHYLLINE - REFERENCE SPECTRUM</p>

<p>COCAINE HYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>La Pharmacopée Européenne (Ph. Eur.) est un ouvrage de référence unique en matière de contrôle qualité des médicaments. Les normes officielles qui y sont publiées fournissent une base scientifique au contrôle qualité durant toute la vie des médicaments.<br><br>Ces normes sont juridiquement contraignantes - ce qui est expressément stipulé dans la Convention relative à l’élaboration d’une Pharmacopée européenne et dans les législations pharmaceutiques nationales et de l’UE. Les normes qualité de la Ph. Eur. deviennent d’application obligatoire à la même date dans tous les États Parties à la convention.<br><br>La 10e Édition en bref<br><br>• Juridiquement contraignante dans 39 pays d’Europe et appliquée dans plus de 120 pays du monde entier<br>• Contient des nouveaux textes et des textes révisés<br>• Divulgue des informations essentielles pour les marchés européens avant toutes les autres pharmacopées<br>• La 10e Edition (Supplément 10.5 inclus) comprend 2447 monographies (y compris les formes pharmaceutiques), 378 textes généraux (y compris les monographies générales et méthodes d’analyse) et environ 2800 descriptions de réactifs.<br><br>Calendrier de parution<br><br>La 10e Édition de la Ph. Eur. a été publiée en juillet 2019 et sera complétée par huit suppléments périodiques (10.1 à 10.8) au cours des trois années suivantes.<br><br>Supplément 10.3 publiée en juillet 2020,<br>Supplément 10.4 publiée en octobre 2020,<br>Supplément 10.5 publiée en janvier 2021.<br><br>Version papier<br><br>La 10e Édition est composée de trois volumes initiaux (10.0), complétés par huit suppléments non cumulatifs (10.1 à 10.8). Par souci de commodité des utilisateurs, un accès direct aux informations complémentaires (base de données Knowledge) est inclus pour chaque monographie et chaque chapitre général (code Datamatrix). Disponible en français ou en anglais, la version papier contient une clé d’activation (code EPID) qui donne accès aux archives en ligne.<br></p>

<p>FLUMAZENIL - REFERENCE SPECTRUM</p>

<p>DIETHYLENE GLYCOL MONOETHYL ETHER - REFERENCE SPECTRUM</p>

<p>SUFENTANIL CITRATE - REFERENCE SPECTRUM</p>